Page 2 - ப்ரெஸிடெஂட் தகவல்தொடர்புகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Latest lecanemab data to be presented at the AD/PD™ congress News provided by Share this article Share this article STOCKHOLM, March 5, 2021 /PRNewswire/ BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the company and its collaboration partner Eisai will both present data relating to its investigational anti-amyloid beta (Aβ) protofibril antibody lecanemab (BAN2401), at the 15th International Conference on Alzheimer s and Parkinson s Diseases and related neurological disorders, AD/PD™ 2021. The International Conference on Alzheimer s and Parkinson s Diseases and related neurological disorders - which due to the ongoing COVID-19 pandemic will be held online - is a key scientific event with a focus on improving the treatment of Alzheimer s, Parkinson s and other related neurodegenerative diseases.

Oskar bossonGunilla osswaldInternational conference on alzheimerNasdaq stockholmInternational conferencePresident communicationsHealth care amp hospitalsMedical pharmaceuticalsClinical trials amp medical discoveriesPolls and researchசர்வதேச மாநாடு ஆன் முதுமறதிநாஸ்டாக் ஸ்டாக்‌ஹோல்ம்சர்வதேச மாநாடுப்ரெஸிடெஂட் தகவல்தொடர்புகள்ஆரோக்கியம் பராமரிப்பு ஆம்ப் மருத்துவமனைகள்உயிரி தொழில்நுட்பவியல்